0001972912-23-000001.txt : 20230412 0001972912-23-000001.hdr.sgml : 20230412 20230412081226 ACCESSION NUMBER: 0001972912-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 EFFECTIVENESS DATE: 20230412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Crossbow Therapeutics, Inc. CENTRAL INDEX KEY: 0001972912 IRS NUMBER: 873073764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-478551 FILM NUMBER: 23814670 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 860-501-1600 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001972912 Crossbow Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 860-501-1600 DELAWARE None None Corporation true 2021 Briggs Morrison 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Todd Foley 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alexandra Cantley 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Irena Melnikova 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Geraldine Paulus 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS Suite 210 Executive Officer Biotechnology Decline to Disclose 06b false 2023-03-29 true true false 0 80000000 37568164 42431836 false 15 0 0 0 false Crossbow Therapeutics, Inc. /s/ Briggs Morrison Briggs Morrison CEO 2023-04-12